Susquehanna Fundamental Investments LLC Acquires Shares of 54,654 The Beauty Health Company (NASDAQ:SKIN)

Susquehanna Fundamental Investments LLC bought a new position in shares of The Beauty Health Company (NASDAQ:SKIN) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 54,654 shares of the company’s stock, valued at approximately $105,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Jacobs Levy Equity Management Inc. acquired a new stake in Beauty Health in the 1st quarter worth about $4,297,000. Federated Hermes Inc. boosted its stake in shares of Beauty Health by 349,616.0% in the second quarter. Federated Hermes Inc. now owns 370,699 shares of the company’s stock worth $712,000 after acquiring an additional 370,593 shares during the last quarter. Sierra Summit Advisors LLC purchased a new stake in shares of Beauty Health during the fourth quarter worth approximately $856,000. Bayesian Capital Management LP acquired a new position in Beauty Health in the 1st quarter valued at $521,000. Finally, Bank of New York Mellon Corp lifted its holdings in Beauty Health by 24.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 348,108 shares of the company’s stock valued at $668,000 after purchasing an additional 69,329 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Up 1.4 %

Shares of NASDAQ SKIN opened at $1.48 on Friday. The company has a market capitalization of $183.55 million, a P/E ratio of -2.11 and a beta of 0.94. The company has a debt-to-equity ratio of 7.96, a current ratio of 6.49 and a quick ratio of 5.47. The company has a 50 day simple moving average of $1.52 and a 200-day simple moving average of $2.33. The Beauty Health Company has a 1 year low of $0.91 and a 1 year high of $5.93.

Beauty Health (NASDAQ:SKIN) last posted its earnings results on Thursday, August 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.05). Beauty Health had a negative return on equity of 4.57% and a negative net margin of 22.86%. The business had revenue of $90.60 million for the quarter, compared to analyst estimates of $98.46 million. On average, equities research analysts predict that The Beauty Health Company will post -0.2 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on SKIN. Canaccord Genuity Group reduced their target price on shares of Beauty Health from $2.00 to $1.25 and set a “hold” rating for the company in a research report on Monday, August 12th. Piper Sandler reiterated an “underweight” rating and issued a $1.00 price objective (down previously from $1.50) on shares of Beauty Health in a report on Friday, August 9th. Finally, Stifel Nicolaus lowered their target price on Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a report on Friday, July 26th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $2.46.

Insiders Place Their Bets

In related news, Chairman Brent L. Saunders purchased 40,450 shares of Beauty Health stock in a transaction dated Monday, August 12th. The shares were acquired at an average cost of $1.08 per share, with a total value of $43,686.00. Following the purchase, the chairman now owns 5,921,769 shares of the company’s stock, valued at approximately $6,395,510.52. The trade was a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 41.00% of the stock is currently owned by insiders.

About Beauty Health

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.